Plain-English translation of NCT06572423 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to radiation therapy called PULSAR for people with head and neck cancer who are not able to have standard treatment. Instead of using traditional radiation schedules, this treatment delivers higher doses in fewer sessions over about two months, and the doctors adjust the plan if your tumor or body changes during treatment. The goal is to better control the cancer while minimizing side effects.
Many patients with head and neck cancer cannot receive the standard treatments that work best, and current palliative (comfort-focused) radiation options don't always keep the cancer under control for as long as needed. This new treatment aims to improve how long patients stay symptom-free and maintain better cancer control, especially as newer cancer drugs are helping people live longer.
You likely qualify if…
You likely don't qualify if…
You will first undergo a CT scan and treatment planning with specialized software to map out exactly where the radiation will go. Then, over about 8 weeks, you will receive five radiation treatments spaced roughly two weeks apart, visiting the hospital on days 0, 14, 28, 42, and 56. If imaging during treatment shows your tumor or body has changed significantly, your doctors may rescan and adjust the plan before your next treatment to keep you safe. You may also have follow-up PET or MRI scans during recovery.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States